시장보고서

상품코드

1908808

에리스로포이에틴 자극제 시장(2026-2030년)

Global Erythropoietin Stimulating Agents Market 2026-2030

발행일: 2026년 01월 | 리서치사:

TechNavio | 페이지 정보: 영문 303 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 에리스로포이에틴 자극제 시장은 2025-2030년간 53억 5,580만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 8.7%를 보일 것으로 예측됩니다. 본 보고서에서는 세계의 에리스로포이에틴 자극제 시장에 관한 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제, 약 25개사 벤더 분석을 제공합니다.

본 보고서는 현재 시장 상황, 최신 시장 동향 및 촉진요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 시장은 만성 신장 질환의 부담 증가, 종양학 및 화학요법 유발성 빈혈의 확대, 전문 신장 치료 및 투석 센터의 보급에 의해 주도되고 있습니다.

이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.

시장 범위
기준 연도	2026년
종료 연도	2030년
예측 기간	2026-2030년
성장 모멘텀	가속
YOY 2026	8.2%
CAGR	8.7%
증가액	53억 5,580만 달러

이 보고서는 향후 몇 년 동안 세계 에리스로포이에틴 자극제 시장의 성장을 주도할 주요 요인 중 하나로 장시간 작용하는 제제와 환자 중심의 투여 요법 증가를 꼽고 있습니다. 또한, 바이오시밀러 분야가 진입 단계에서 생태계 지배 단계로 성숙하고, 개인별 맞춤 빈혈 관리 및 보수적 투여로의 패러다임 전환이 진행됨에 따라 시장에서 상당한 수요가 발생할 것으로 예측됩니다.

기업 개요
기업 순위 지표
기업의 시장 포지셔닝
Amgen Inc.
Biocon Ltd.
Dr Reddys Laboratories Ltd.
F. Hoffmann La Roche Ltd.
Intas Pharmaceuticals Ltd.
Johnson and Johnson Services
Kyowa Kirin Co. Ltd.
LG Chem Ltd.
Novartis AG
Pfizer Inc.
Reliance Industries Ltd.
Sandoz Group AG
STADA Arzneimittel AG
Teva Pharmaceutical Ltd.
Zydus Lifesciences Ltd.

제16장 부록

LSH 26.01.30

The global erythropoietin stimulating agents market is forecasted to grow by USD 5355.8 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global erythropoietin stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating burden of chronic kidney diseases, expanding landscape of oncology and chemotherapy induced anemia, proliferation of specialized renal care and dialysis centers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	8.2%
CAGR	8.7%
Incremental Value	$5355.8 mn

Technavio's global erythropoietin stimulating agents market is segmented as below:

By Type

Epoetin alfa
Epoetin beta
Darbepoetin alfa
Others

By Indication

CKD
Chemotherapy induced anemia
Perioperative anemia
Others

By End-User

Dialysis centers
Hospitals
Oncology clinics
Others

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the ascendancy of long-acting formulations and patient centric dosing regimens as one of the prime reasons driving the global erythropoietin stimulating agents market growth during the next few years. Also, maturation of biosimilar sector from entry to ecosystem dominance and paradigm shift toward personalized anemia management and conservative dosing will lead to sizable demand in the market.

The report on the global erythropoietin stimulating agents market covers the following areas:

Global erythropoietin stimulating agents market sizing
Global erythropoietin stimulating agents market forecast
Global erythropoietin stimulating agents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global erythropoietin stimulating agents market vendors that include Akebia Therapeutics, Amgen Inc., Biocon Ltd., Biosidus SA, Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services, Kyowa Kirin Co. Ltd., LG Chem Ltd., Nanogen Pharmaceuticals, Novartis AG, Pfizer Inc., Reliance Industries Ltd., Sandoz Group AG, STADA Arzneimittel AG, Teva Pharmaceutical Ltd., Zydus Lifesciences Ltd.. Also, the global erythropoietin stimulating agents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5 Historic Market Size

5.1 Global Erythropoietin Stimulating Agents Market 2020 - 2024
- Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global erythropoietin stimulating agents market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Epoetin alfa - Market size and forecast 2025-2030
- Chart on Epoetin alfa - Market size and forecast 2025-2030 ($ million)
- Data Table on Epoetin alfa - Market size and forecast 2025-2030 ($ million)
- Chart on Epoetin alfa - Year-over-year growth 2025-2030 (%)
- Data Table on Epoetin alfa - Year-over-year growth 2025-2030 (%)
8.4 Epoetin beta - Market size and forecast 2025-2030
- Chart on Epoetin beta - Market size and forecast 2025-2030 ($ million)
- Data Table on Epoetin beta - Market size and forecast 2025-2030 ($ million)
- Chart on Epoetin beta - Year-over-year growth 2025-2030 (%)
- Data Table on Epoetin beta - Year-over-year growth 2025-2030 (%)
8.5 Darbepoetin alfa - Market size and forecast 2025-2030
- Chart on Darbepoetin alfa - Market size and forecast 2025-2030 ($ million)
- Data Table on Darbepoetin alfa - Market size and forecast 2025-2030 ($ million)
- Chart on Darbepoetin alfa - Year-over-year growth 2025-2030 (%)
- Data Table on Darbepoetin alfa - Year-over-year growth 2025-2030 (%)
8.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Indication

9.1 Market segments
- Chart on Indication - Market share 2025-2030 (%)
- Data Table on Indication - Market share 2025-2030 (%)
9.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
9.3 CKD - Market size and forecast 2025-2030
- Chart on CKD - Market size and forecast 2025-2030 ($ million)
- Data Table on CKD - Market size and forecast 2025-2030 ($ million)
- Chart on CKD - Year-over-year growth 2025-2030 (%)
- Data Table on CKD - Year-over-year growth 2025-2030 (%)
9.4 Chemotherapy induced anemia - Market size and forecast 2025-2030
- Chart on Chemotherapy induced anemia - Market size and forecast 2025-2030 ($ million)
- Data Table on Chemotherapy induced anemia - Market size and forecast 2025-2030 ($ million)
- Chart on Chemotherapy induced anemia - Year-over-year growth 2025-2030 (%)
- Data Table on Chemotherapy induced anemia - Year-over-year growth 2025-2030 (%)
9.5 Perioperative anemia - Market size and forecast 2025-2030
- Chart on Perioperative anemia - Market size and forecast 2025-2030 ($ million)
- Data Table on Perioperative anemia - Market size and forecast 2025-2030 ($ million)
- Chart on Perioperative anemia - Year-over-year growth 2025-2030 (%)
- Data Table on Perioperative anemia - Year-over-year growth 2025-2030 (%)
9.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Dialysis centers - Market size and forecast 2025-2030
- Chart on Dialysis centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Dialysis centers - Market size and forecast 2025-2030 ($ million)
- Chart on Dialysis centers - Year-over-year growth 2025-2030 (%)
- Data Table on Dialysis centers - Year-over-year growth 2025-2030 (%)
10.4 Hospitals - Market size and forecast 2025-2030
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
10.5 Oncology clinics - Market size and forecast 2025-2030
- Chart on Oncology clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncology clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Oncology clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Oncology clinics - Year-over-year growth 2025-2030 (%)
10.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2025-2030
  - Chart on US - Market size and forecast 2025-2030 ($ million)
  - Data Table on US - Market size and forecast 2025-2030 ($ million)
  - Chart on US - Year-over-year growth 2025-2030 (%)
  - Data Table on US - Year-over-year growth 2025-2030 (%)
- 12.3.2 Canada - Market size and forecast 2025-2030
  - Chart on Canada - Market size and forecast 2025-2030 ($ million)
  - Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  - Chart on Canada - Year-over-year growth 2025-2030 (%)
  - Data Table on Canada - Year-over-year growth 2025-2030 (%)
- 12.3.3 Mexico - Market size and forecast 2025-2030
  - Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  - Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  - Chart on Mexico - Year-over-year growth 2025-2030 (%)
  - Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2025-2030
  - Chart on Germany - Market size and forecast 2025-2030 ($ million)
  - Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  - Chart on Germany - Year-over-year growth 2025-2030 (%)
  - Data Table on Germany - Year-over-year growth 2025-2030 (%)
- 12.4.2 France - Market size and forecast 2025-2030
  - Chart on France - Market size and forecast 2025-2030 ($ million)
  - Data Table on France - Market size and forecast 2025-2030 ($ million)
  - Chart on France - Year-over-year growth 2025-2030 (%)
  - Data Table on France - Year-over-year growth 2025-2030 (%)
- 12.4.3 UK - Market size and forecast 2025-2030
  - Chart on UK - Market size and forecast 2025-2030 ($ million)
  - Data Table on UK - Market size and forecast 2025-2030 ($ million)
  - Chart on UK - Year-over-year growth 2025-2030 (%)
  - Data Table on UK - Year-over-year growth 2025-2030 (%)
- 12.4.4 Italy - Market size and forecast 2025-2030
  - Chart on Italy - Market size and forecast 2025-2030 ($ million)
  - Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  - Chart on Italy - Year-over-year growth 2025-2030 (%)
  - Data Table on Italy - Year-over-year growth 2025-2030 (%)
- 12.4.5 Spain - Market size and forecast 2025-2030
  - Chart on Spain - Market size and forecast 2025-2030 ($ million)
  - Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  - Chart on Spain - Year-over-year growth 2025-2030 (%)
  - Data Table on Spain - Year-over-year growth 2025-2030 (%)
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
  - Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  - Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2025-2030
  - Chart on China - Market size and forecast 2025-2030 ($ million)
  - Data Table on China - Market size and forecast 2025-2030 ($ million)
  - Chart on China - Year-over-year growth 2025-2030 (%)
  - Data Table on China - Year-over-year growth 2025-2030 (%)
- 12.5.2 Japan - Market size and forecast 2025-2030
  - Chart on Japan - Market size and forecast 2025-2030 ($ million)
  - Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  - Chart on Japan - Year-over-year growth 2025-2030 (%)
  - Data Table on Japan - Year-over-year growth 2025-2030 (%)
- 12.5.3 India - Market size and forecast 2025-2030
  - Chart on India - Market size and forecast 2025-2030 ($ million)
  - Data Table on India - Market size and forecast 2025-2030 ($ million)
  - Chart on India - Year-over-year growth 2025-2030 (%)
  - Data Table on India - Year-over-year growth 2025-2030 (%)
- 12.5.4 South Korea - Market size and forecast 2025-2030
  - Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  - Chart on South Korea - Year-over-year growth 2025-2030 (%)
  - Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- 12.5.5 Thailand - Market size and forecast 2025-2030
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- 12.5.6 Indonesia - Market size and forecast 2025-2030
  - Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  - Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Brazil - Market size and forecast 2025-2030
  - Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  - Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  - Chart on Brazil - Year-over-year growth 2025-2030 (%)
  - Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  - Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  - Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- 12.6.3 UAE - Market size and forecast 2025-2030
  - Chart on UAE - Market size and forecast 2025-2030 ($ million)
  - Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  - Chart on UAE - Year-over-year growth 2025-2030 (%)
  - Data Table on UAE - Year-over-year growth 2025-2030 (%)
- 12.6.4 Turkey - Market size and forecast 2025-2030
  - Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  - Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  - Chart on Turkey - Year-over-year growth 2025-2030 (%)
  - Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- 12.6.5 Argentina - Market size and forecast 2025-2030
  - Chart on Argentina - Market size and forecast 2025-2030 ($ million)
  - Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
  - Chart on Argentina - Year-over-year growth 2025-2030 (%)
  - Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- 12.6.6 South Africa - Market size and forecast 2025-2030
  - Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  - Chart on South Africa - Year-over-year growth 2025-2030 (%)
  - Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- 12.6.7 Israel - Market size and forecast 2025-2030
  - Chart on Israel - Market size and forecast 2025-2030 ($ million)
  - Data Table on Israel - Market size and forecast 2025-2030 ($ million)
  - Chart on Israel - Year-over-year growth 2025-2030 (%)
  - Data Table on Israel - Year-over-year growth 2025-2030 (%)
- 12.6.8 Colombia - Market size and forecast 2025-2030
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Escalating burden of chronic kidney diseases
- Expanding landscape of oncology and chemotherapy induced anemia
- Proliferation of specialized renal care and dialysis centers
13.2 Market challenges
- Pervasive safety concerns and rigorous regulatory oversight
- Intensifying price erosion from biosimilar competition
- Emergence of novel therapeutic alternatives
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Ascendancy of long-acting formulations and patient centric dosing regimens
- Maturation of biosimilar sector from entry to ecosystem dominance
- Paradigm shift toward personalized anemia management and conservative dosing

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.5 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
15.6 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.8 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
15.9 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
15.10 Kyowa Kirin Co. Ltd.
- Kyowa Kirin Co. Ltd. - Overview
- Kyowa Kirin Co. Ltd. - Business segments
- Kyowa Kirin Co. Ltd. - Key offerings
- Kyowa Kirin Co. Ltd. - Segment focus
- SWOT
15.11 LG Chem Ltd.
- LG Chem Ltd. - Overview
- LG Chem Ltd. - Business segments
- LG Chem Ltd. - Key news
- LG Chem Ltd. - Key offerings
- LG Chem Ltd. - Segment focus
- SWOT
15.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.14 Reliance Industries Ltd.
- Reliance Industries Ltd. - Overview
- Reliance Industries Ltd. - Business segments
- Reliance Industries Ltd. - Key news
- Reliance Industries Ltd. - Key offerings
- Reliance Industries Ltd. - Segment focus
- SWOT
15.15 Sandoz Group AG
- Sandoz Group AG - Overview
- Sandoz Group AG - Product / Service
- Sandoz Group AG - Key offerings
- SWOT
15.16 STADA Arzneimittel AG
- STADA Arzneimittel AG - Overview
- STADA Arzneimittel AG - Business segments
- STADA Arzneimittel AG - Key offerings
- STADA Arzneimittel AG - Segment focus
- SWOT
15.17 Teva Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
15.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

에리스로포이에틴 자극제 시장(2026-2030년)

Global Erythropoietin Stimulating Agents Market 2026-2030

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 유형별

제9장 시장 세분화 : 적응증별

제10장 시장 세분화 : 최종사용자별

제11장 고객 상황

제12장 지역별 상황

제13장 성장 촉진요인, 과제 및 기회

제14장 경쟁 구도

제15장 경쟁 분석